Polysaccharide-based copolymers for high-resolution oligopeptide chromatography
A novel approach using polysaccharide-based copolymers with tunable pore sizes designed for the high-resolution chromatography of oligopeptides. This method addresses challenges in purification by allowing specific affinity ligand integration, enhancing purification efficacy.
Overview
The research focuses on developing polysaccharide-based copolymers for high-resolution chromatography, specifically targeting the purification of oligopeptides. This innovative approach addresses the limitations faced in conventional synthetic resin chromatography, which struggles with gradient pore distribution and cross-linking of pH/temperature-sensitive affinity ligands. By leveraging tunable pore sizes and easy cross-linking capabilities, the developed materials serve as an ideal filler matrix for chromatography columns, enhancing the purification process for oligopeptides.
Technical specifications
- Polysaccharide-based copolymers: These materials are designed with tunable pore sizes, allowing for precise control over the chromatographic process.
- Cross-linkable for specific ligands: The copolymers are engineered to easily integrate fragile specific affinity groups, including those with antibody structures or nucleophilic/electrophilic domains.
- High-resolution capability: The matrix supports high-resolution chromatography, crucial for effective oligopeptide purification.
- Overcoming conventional limitations: Unlike synthetic resin matrices, these copolymers facilitate a gradient distribution of internal pores, optimizing purification efficacy.
Technology readiness level
This technology is at a TRL of 4, indicating that it has been validated in a laboratory environment, with ongoing development to demonstrate its effectiveness in operational settings.
About General Molecular Expression Service Pty Ltd (GMES))
General Molecular Expression Service Pty Ltd (GMES), known as GMExpression, is a biotechnology company incorporated in 2021 and based at the University of Adelaide’s Waite Campus. The company specializes in the development of cell-free protein expression systems, including its proprietary CFPS+ platform. This technology is designed as a low-cost, efficient, and scalable solution for the production of proteins and functional macromolecules. GMES offers a range of services from lab-scale synthesis to large-scale industrial production, supporting complex processes such as codon optimization, protein folding prediction, and purification. Their technological approach integrates advanced metabolic subsystems, including artificial mitochondria and nucleotide anabolic pathways, to enable dynamic and continuous flow production.
The company provides critical infrastructure and materials for researchers, medical applications, and material science, including the synthesis of toxic or difficult-to-express proteins. Beyond its core protein expression services, GMES maintains an online shop supplying laboratory reagents, specialized culture media, and kits such as its Pichia pastoris expression system. Through research collaborations, the company is also expanding into iPSC-derived therapies, organoids, and innovative cultivation protocols. GMES leverages its own commercial profits to support research and development initiatives, often partnering with academic institutions and scholars to advance biotechnological innovation.
delivered to your inbox.